BACKGROUND: Ventilatory efficiency, assessed by the slope of minute ventilation (VE) versus carbon dioxide production (VCO(2)), is a powerful prognostic marker in patients with chronic heart failure. We hypothesized that VE/VCO(2) slope would be more accurate than the current listing criteria for heart transplantation (HTx) in identifying patients likely to derive a survival benefit from this intervention. METHODS AND RESULTS: A total of 663 patients with chronic heart failure who underwent cardiopulmonary exercise testing were tracked for cardiac mortality and HTx. Ve/Vco(2) slope was the strongest independent predictor of mortality. Using a VE/VCO(2) slope threshold instead of the current exercise criteria would classify 39 more subjects as being high risk (196 versus 157), correctly identifying 19 more patients who died during follow-up (57 versus 38) and 16 others who underwent transplantation (52 versus 36). Unlike the current listing criteria for HTx, VE/VCO(2) slope provided significant discrimination between the 3-year survival of high- and low-risk patients and posttransplant patients selected from the International Society for Heart and Lung Transplantation registry. Reanalysis of survival data using death or HTx as the end point showed similar results. CONCLUSIONS: VE/VCO(2) slope is more accurate than the current listing criteria for HTx in identifying patients likely to derive a survival benefit from HTx.
BACKGROUND: Ventilatory efficiency, assessed by the slope of minute ventilation (VE) versus carbon dioxide production (VCO(2)), is a powerful prognostic marker in patients with chronic heart failure. We hypothesized that VE/VCO(2) slope would be more accurate than the current listing criteria for heart transplantation (HTx) in identifying patients likely to derive a survival benefit from this intervention. METHODS AND RESULTS: A total of 663 patients with chronic heart failure who underwent cardiopulmonary exercise testing were tracked for cardiac mortality and HTx. Ve/Vco(2) slope was the strongest independent predictor of mortality. Using a VE/VCO(2) slope threshold instead of the current exercise criteria would classify 39 more subjects as being high risk (196 versus 157), correctly identifying 19 more patients who died during follow-up (57 versus 38) and 16 others who underwent transplantation (52 versus 36). Unlike the current listing criteria for HTx, VE/VCO(2) slope provided significant discrimination between the 3-year survival of high- and low-risk patients and posttransplant patients selected from the International Society for Heart and Lung Transplantation registry. Reanalysis of survival data using death or HTx as the end point showed similar results. CONCLUSIONS: VE/VCO(2) slope is more accurate than the current listing criteria for HTx in identifying patients likely to derive a survival benefit from HTx.
Authors: Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie Journal: Expert Rev Respir Med Date: 2011-04 Impact factor: 3.772
Authors: Steven J Keteyian; Mahesh Patel; William E Kraus; Clinton A Brawner; Timothy R McConnell; Ileana L Piña; Eric S Leifer; Jerome L Fleg; Gordon Blackburn; Gregg C Fonarow; Paul J Chase; Lucy Piner; Marianne Vest; Christopher M O'Connor; Jonathan K Ehrman; Mary N Walsh; Gregory Ewald; Dan Bensimhon; Stuart D Russell Journal: J Am Coll Cardiol Date: 2016-02-23 Impact factor: 24.094
Authors: Artur Haddad Herdy; Luiz Eduardo Fonteles Ritt; Ricardo Stein; Claudio Gil Soares de Araújo; Mauricio Milani; Romeu Sérgio Meneghelo; Almir Sérgio Ferraz; Carlos Hossri; Antonio Eduardo Monteiro de Almeida; Miguel Morita Fernandes-Silva; Salvador Manoel Serra Journal: Arq Bras Cardiol Date: 2016-11 Impact factor: 2.000
Authors: Jingyi Gong; Renata R T Castro; Jesse P Caron; Camden P Bay; Jon Hainer; Alexander R Opotowsky; Mandeep R Mehra; Bradley A Maron; Marcelo F Di Carli; John D Groarke; Anju Nohria Journal: ESC Heart Fail Date: 2021-12-21